The FDA has approved a…
The FDA has approved a once-weekly subcutaneous maintenance dose of Leqembi [...]
The FDA has approved a once-weekly subcutaneous maintenance dose of Leqembi [...]
Wegovy’s mechanism of action could be ideal for patients with [...]
Flying high after an FDA approval four months ago to [...]
Pfizer is taking a curtain call for Vyndaqel, the low-dose [...]
Amid a growing push for more direct-to-consumer access to some [...]
The University of Michigan is suing AstraZeneca over claims that [...]
Patients in the U.S. now have access to the first [...]
The Leukemia & Lymphoma Society is marking Blood Cancer Awareness [...]
The private equity-owned company held off on a previously planned [...]
After Maze Therapeutics opted not to participate in the National [...]